NARA Discovery
Article Details
← Back to Search Results
Journal Article

Dried leaves of Rosmarinus officinalis as a treatment for streptococcosis in tilapia

D Zilberg; A Tal; N Froyman; S Abutbul; N Dudai; A Golan‐Goldhirsh
Journal of Fish Diseases · Vol. 33, Issue 4 · pp. 361-369 · 2010

Abstract

Dietary application of dried Rosmarinus officinalis (rosemary) leaves as a treatment for streptococcal infection was studied in tilapia, Oreochromis sp. Feeding with dried rosemary leaves significantly reduced mortality following infection with Streptococcus iniae : 44% mortality in the group fed 8% rosemary, similar to oxytetracycline treatment (43% mortality), and significantly lower than the control (65%). Dietary administration of 16% rosemary significantly reduced mortality because of Streptococcus agalactiae infection in 44 g fish (62% and 76% in 16% rosemary and control, respectively), but not in a similar experiment conducted with 5.5 g fish. The antibacterial effect of rosemary on S. iniae was studied. Activity of rosemary cultivar Israel was reduced during the winter, but there was no significant change in cultivars Oranit and Star. Storage of powdered rosemary leaves at 50 °C resulted in fourfold and eightfold higher MIC 24 h values after 3 and 4.5 months, respectively. Storage at −20 °C, 4 °C and 25 °C and autoclaving (120 °C) each resulted in a twofold increase in MIC 24 h . Repeated exposures of S. iniae to rosemary did not affect minimal inhibitory concentration, suggesting no development of resistance to rosemary.

Bibliographic Information

JournalJournal of Fish Diseases
PublisherWiley
Publication Date2010-04-01
Publication Year2010
Volume33
Issue4
Pages361-369
Document TypeJournal Article
Print ISSN0140-7775
eISSN1365-2761
DOI10.1111/j.1365-2761.2009.01129.x
SubjectGeneral Aquaculture, Fisheries & Fish Science

Access Information

NARA Access Coverage1997-01-01~Current
Journal Homepagehttps://onlinelibrary.wiley.com/loi/13652761
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.